IRIS UniCatt

Lo Monaco, Maria Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.153
AS - Asia 2.766
EU - Europa 2.471
SA - Sud America 598
AF - Africa 119
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.120
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.038
SG - Singapore 1.351
CN - Cina 610
IT - Italia 603
BR - Brasile 508
SE - Svezia 441
DE - Germania 389
FR - Francia 214
HK - Hong Kong 169
IE - Irlanda 167
GB - Regno Unito 149
VN - Vietnam 140
ID - Indonesia 107
IN - India 93
FI - Finlandia 85
RU - Federazione Russa 75
CA - Canada 65
PL - Polonia 63
UA - Ucraina 55
BE - Belgio 54
CI - Costa d'Avorio 51
KR - Corea 44
TR - Turchia 44
NL - Olanda 42
AT - Austria 38
MX - Messico 36
IQ - Iraq 35
AR - Argentina 29
BD - Bangladesh 29
JP - Giappone 26
ZA - Sudafrica 26
IR - Iran 22
ES - Italia 20
EC - Ecuador 18
SA - Arabia Saudita 18
CZ - Repubblica Ceca 14
CH - Svizzera 13
VE - Venezuela 13
IL - Israele 10
PK - Pakistan 10
JO - Giordania 9
UZ - Uzbekistan 9
CO - Colombia 8
KE - Kenya 8
AU - Australia 7
GR - Grecia 7
EG - Egitto 6
LT - Lituania 6
MA - Marocco 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
PH - Filippine 5
CL - Cile 4
DZ - Algeria 4
EU - Europa 4
LU - Lussemburgo 4
NI - Nicaragua 4
PY - Paraguay 4
UY - Uruguay 4
AZ - Azerbaigian 3
DK - Danimarca 3
EE - Estonia 3
HU - Ungheria 3
KW - Kuwait 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
PE - Perù 3
RS - Serbia 3
SN - Senegal 3
TN - Tunisia 3
AL - Albania 2
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
CY - Cipro 2
HN - Honduras 2
KG - Kirghizistan 2
MK - Macedonia 2
MY - Malesia 2
NG - Nigeria 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SR - Suriname 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BF - Burkina Faso 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GT - Guatemala 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 9.108
Salva come PNG Salva come JPEG
Città #
Singapore 679
Chandler 437
Ashburn 420
Dublin 165
Rome 150
New York 142
Beijing 132
Milan 124
Ann Arbor 119
Hefei 108
Jakarta 97
Los Angeles 94
The Dalles 86
Dallas 79
Chicago 76
Munich 62
Warsaw 54
Hong Kong 52
São Paulo 52
Abidjan 51
Frankfurt am Main 50
Ho Chi Minh City 49
Cattolica 47
Boardman 46
Moscow 46
Helsinki 45
Boston 44
Brussels 44
Princeton 43
San Mateo 43
Wilmington 42
Houston 37
Marseille 37
Hanoi 35
Seoul 35
Kent 34
North Bergen 33
Jacksonville 28
Nanjing 28
Dearborn 26
London 25
Nuremberg 25
Ottawa 25
Woodbridge 24
Tokyo 23
Fairfield 22
Washington 22
Izmir 21
Redwood City 21
Turku 21
Amsterdam 20
Bremen 19
Rio de Janeiro 19
Vienna 19
Brooklyn 17
Denver 17
Johannesburg 17
Trieste 17
Buffalo 16
Cambridge 16
Pune 15
Seattle 15
Düsseldorf 14
Atlanta 13
Baghdad 13
Belo Horizonte 13
Lancaster 13
Phoenix 13
Santa Clara 13
Council Bluffs 12
Lappeenranta 12
Leawood 12
Nürnberg 12
Brno 11
Chennai 11
Kish 11
Manchester 11
Mexico City 11
Norwalk 11
Poplar 11
Redmond 11
Stockholm 11
Toronto 11
Augusta 10
Falkenstein 10
Guangzhou 10
Portsmouth 10
Roubaix 10
Ankara 9
Montreal 9
Paris 9
Amman 8
Andover 8
Goiânia 8
Jiaxing 8
Riyadh 8
Shanghai 8
Tashkent 8
Zurich 8
Afragola 7
Totale 4.805
Salva come PNG Salva come JPEG
Nome #
Teaching neuroimages: Peroneal intraneural ganglion cyst: a rare cause of drop foot in a child. 239
The role of cognitive reserve in cognitive aging: what we can learn from Parkinson’s disease Select item 29019160 1. The role of cognitive reserve in cognitive aging: what we can learn from Parkinson's disease. 196
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 193
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 186
Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease 186
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 171
Assessment of neurological manifestations in hospitalized patients with COVID-19 170
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 169
Residual respiratory impairment after COVID-19 pneumonia 146
Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study 146
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 145
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 144
COVID-19 atypical Parsonage-Turner syndrome: a case report 142
The impact of cognitive reserve on the effectiveness of balance rehabilitation in Parkinson's disease 142
Laterality in Parkinson's disease may predict motor and visual imagery abilities 142
Malnutrition in COVID-19 survivors: prevalence and risk factors 137
Residual respiratory impairment after COVID-19 pneumonia 137
Use of ACE-inhibitors and falls in patients with Parkinson's disease 136
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 136
The “development of metabolic and functional markers of dementia in older people” (ODINO) study: Rationale, design and methods 132
The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection 123
Association of metabolic syndrome with falls in patients with Parkinson's disease 121
Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease 121
The Geriatrician: The Frontline Specialist in the Treatment of COVID-19 Patients 120
Comparison of virtual reality rehabilitation and conventionalrehabilitation in Parkinson’s disease: a randomised controlledtrial 118
Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study 114
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 112
Use of proton-pump inhibitors is associated with depression: a population-based study 111
What about the caregiver? A journey into Parkinson’s disease following the burden tracks 111
Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors 107
Safinamide as an adjunct therapy in older patients with Parkinson’s disease: a retrospective study 105
Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study 104
F057 Affective and cognitive components of theory of mind in Huntington’s disease: yoni task performance in early and mid-disease stages 101
Word selection processing in Parkinson's disease: When nouns are more difficult than verbs 101
Polypharmacy is a determinant of hospitalization in Parkinson's disease 101
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 99
Gender may be related to the side of the motorsyndrome and cognition in idiopathic Parkinson’sdisease 99
Association between frailty and ischemic heart disease: a systematic review and meta-analysis 99
Untangling the relationship between fat distribution, nutritional status and Parkinson's disease severity 98
Sarcopenia in Parkinson Disease: Comparison of Different Criteria and Association With Disease Severity 98
Writing errors in primary progressive aphasia 98
Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation 93
Mitochondrial dysfunction and aging: Insights from the analysis of extracellular vesicles 93
Circulating amino acid signature in older people with Parkinson's disease: A metabolic complement to the EXosomes in PArkiNson Disease (EXPAND) study 93
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 92
Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease 88
Association of Pisa Syndrome With Mortality in Patients With Parkinson's Disease 86
Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19 85
What about the caregiver? A journey into Parkinson's disease following the burden tracks 84
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 84
Should face masks be worn to contain the spread of COVID-19 in the postlockdown phase? 82
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end? 82
The Geriatrician: The Frontline Specialist in the Treatment of COVID-19 Patients 81
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 81
Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation 80
Should face masks be worn to contain the spread of COVID-19 in the postlockdown phase? 80
Social cognition in Parkinson's disease and functional movement disorders 79
Balancing the risks and benefits of antipsychotic medications for symptom management in older patients with cancer 79
Theory of mind: A clue for the interpretation of functional movement disorders 78
Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease 77
Safinamide as an adjunct therapy in older patients with Parkinson's disease: a retrospective study 76
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up 75
Association between frailty and ischemic heart disease: a systematic review and meta-analysis 74
The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection 74
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 73
Social cognition in basal ganglia pathologies: Theory of Mind in Huntington's and Parkinson's diseases 72
Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19 72
Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease 72
Impaired processing of conspecifics in Parkinson's disease 71
Emotional valence may influence memory performance for visual artworks in Parkinson’s disease 71
Comparison of virtual reality rehabilitation and conventional rehabilitation in Parkinson's disease: a randomised controlled trial 71
Encephalopathy as neurological involvement of SARS-COV-2 infection 69
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 67
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up 67
Writing errors in primary progressive aphasia 66
An educational case series of Parkinson's disease during the COVID-19 pandemic 66
Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey 65
Correction to: Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 64
An educational case series of Parkinson's disease during the COVID-19 pandemic 64
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end? 64
Correction to: Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington’s disease (Journal of Neurology, (2022), 269, 12, (6634-6640), 10.1007/s00415-022-11297-3) 61
Fucntional and clinical correlates of carotid intimal thickness in obstructive sleep apnea syndrome 59
STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson's disease 58
Clinical and MRI characterization of apraxic syndrome in corticobasal degeneration: A single-case study 57
Theory of mind: A clue for the interpretation of functional movement disorders 55
Of microbes and minds: A narrative review on the second brain aging 55
Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure 54
Social cognition in basal ganglia pathologies: Theory of Mind in Huntington’s and Parkinson’s diseases 52
The effects of cognitive impairment on mortality among hospitalized patients with heart failure 51
Subacute onset dystonia in a woman affected by Parkinson's disease following SARS-COV-2 infection 51
The “development of metabolic and functional markers of dementia in older people” (ODINO) study: Rationale, design and methods 49
Assessment of neurological manifestations in hospitalized patients with COVID-19 48
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 44
Subacute onset dystonia in a woman affected by Parkinson's disease following SARS-COV-2 infection 41
Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson's Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study 34
Coronary risk factors in the elderly: Their interactions and treatment 28
Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson's Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study 21
An early feasibility study for neurological devices: The ARCTRAN study 13
Neuropsychological measures of post-COVID-19 cognitive status 8
Totale 9.285
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.375
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 0 0 0 0 0 25 58 14 30 46 47 20
2021/2022540 38 21 13 44 31 18 15 81 15 43 107 114
2022/20231.586 160 167 85 215 73 165 108 103 332 87 76 15
2023/20241.182 37 245 74 83 75 198 76 63 16 73 101 141
2024/20252.180 50 51 168 90 169 101 90 76 302 218 483 382
2025/20262.800 727 203 384 613 828 45 0 0 0 0 0 0
Totale 9.285